NCT00444782View on ClinicalTrials.gov

A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma.

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Carcinoma, Hepatocellular
Interventions
BIOLOGICAL

GV1001

Trial Locations (3)

30625

Tim F. Greten, Hanover

93143

Michel Beaugrand, Bondy

E-08036

Jordi Bruix, Barcelona

Sponsors

Lead Sponsor

Pharmexa A/S
All Listed Sponsors
lead

Pharmexa A/S

INDUSTRY

NCT00444782 - A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. | Biotech Hunter | Biotech Hunter